Chelsea M. Black

发表

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential

Yiming Li, L. Young, E. Carter, 2017, Oncoimmunology.

Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells

E. Jaffee, G. Sgouros, Chelsea M. Black, 2012, PloS one.

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

R. Minter, A. Sandercock, J. Bradley, 2016, Oncotarget.

Nondominant CD8 T Cells Are Active Players in the Vaccine-Induced Antitumor Immune Response

E. Jaffee, J. Uram, Lanqing Huang, 2011, The Journal of Immunology.

Immune Response Players in the Vaccine-Induced Antitumor Nondominant CD8 T Cells Are Active

E. Jaffee, J. Uram, Lanqing Huang, 2011 .

MyD 88-Dependent SHIP 1 Regulates Proinflammatory Signaling Pathways in Dendritic Cells after Monophosphoryl Lipid A Stimulation of TLR 4

P. Klenerman, E. Jaffee, L. Boon, 2011 .

Regulation of NT-PGC-1α Subcellular Localization and Function by Protein Kinase A-dependent Modulation of Nuclear Export by CRM1*

T. Gettys, P. Huypens, Chelsea M. Black, 2010, The Journal of Biological Chemistry.

Apoptosis-Regulated Low-Avidity Cancer-Specific CD8+ T Cells Can Be Rescued to Eliminate HER2/neu–Expressing Tumors by Costimulatory Agonists in Tolerized Mice

E. Jaffee, Chelsea M. Black, T. Armstrong, 2014, Cancer Immunology Research.

Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane.

M. Gottesman, G. Szakács, S. Akiyama, 2007, Biochemistry.

Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody: A phase 1, open-label study in advanced malignancies

O. Hamid, J. Gray, L. Chow, 2016 .